首页> 外文会议>Annual meeting of the Society for Biomaterials >SYNTHESIS AND CHARACTERIZATION OF DENDRIMER-DRUG NANODEVICES TO TARGET PERIPROSTHETIC INFLAMMATION
【24h】

SYNTHESIS AND CHARACTERIZATION OF DENDRIMER-DRUG NANODEVICES TO TARGET PERIPROSTHETIC INFLAMMATION

机译:树枝状药物纳米装置的合成和表征以靶向包膜发炎

获取原文

摘要

PAMAM -EM nanodevice was developed for periprosthetic inflammation treatment. Drug payload was -16% by weight, which is relatively high for polymer conjugates, yet very soluble in PBS. Conjugate released the drug effectively, with > 90% of free drug over a period of lOh. Conjugate was non cytotoxic to RAW 264.7 cells. Conjugate was more effective in reducing NO" production (a measure of anti-inflammatory activity) compared to free drug, in LPS activated macrophages. Antibacterial activity of the conjugate was comparable to free drug.
机译:开发了PAMAM -EM纳米设备用于假体周围炎症治疗。药物有效载荷为-16%(重量),对于聚合物结合物而言相对较高,但非常易溶于PBS。共轭物有效地释放了药物,在10h的时间内有> 90%的游离药物。结合物对RAW 264.7细胞无细胞毒性。与LPS活化的巨噬细胞相比,结合物与游离药物相比在减少NO“的产生(抗炎活性的措施)方面更有效。结合物的抗菌活性与游离药物相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号